| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |